Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Contact information


eileen.parkes@oncology.ox.ac.uk

Eileen Parkes

MB BCh, Ba(O) (Hons), MRCP (Onc), PhD

ASSOCIATE PROFESSOR, INNATE TUMOUR IMMUNOLOGY, Group leader

  • Consultant Medical Oncologist, Early Phase Trials

RESEARCH SUMMARY

  • Understand resistance mechanisms to immune-targeting treatments in cancer;
  • Characterise the role of the interaction of chromosomal instability and DNA repair deficiency with immune activation in tumour initiation, progression and response.
  • Study tumour microenvironment, fibroblasts and extracellular matrix in chromosomally unstable cancers.


In the Parkes Lab we study intrinsic inflammatory pathways in cancer. These are important immune pathways, present in all cells, that act as emergency response pathways to viral infection. However, in cancer, these pathways can be rewired and hijacked by the tumour to promote growth, invasion and metastasis.

Recent publications

More publications